Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Condition:   Esophageal Squamous Cell Carcinoma
Interventions:   Drug: Irinotecan;   Drug: Apatinib
Sponsors:   Peking University;   Beijing Cancer Hospital
Recruiting - verified August 2017

http://ift.tt/2i5khq6